BMY Income Statement

Bristol Myers Squibb Co - Revenue, Expenses & Profit Analysis

Stock Price

$62.37

Market Cap

$127.01B

P/E Ratio

18.0

EPS (TTM)

$3.46

Most Recent Quarter

Period: FY(2025-12-31)

Revenue

Total sales from operations

$48.19B

-0.2% YoY

Cost of Revenue

Direct costs of sales

$13.94B

Gross Profit

Revenue - Cost of Revenue

$34.26B

Margin: 72.6%

Net Income

Bottom line profit

$7.05B

Margin: 0.1%

Earnings Per Share (Diluted)

Net income per share

$3.46

Profitability Metrics

Gross Margin

72.6%

Operating Margin

0.3%

Net Margin

0.1%

Return on Equity

0.4%

Historical Income Statements

PeriodRevenueGross ProfitOperating IncomeNet IncomeEPS
FY$48.19B$34.26B-$7.05B$3.46
FY$48.30B$34.33B-$-8.95B$-4.41
FY$45.01B$34.31B-$8.03B$3.86
FY$46.16B$36.02B-$6.33B$2.95
FY$46.38B$36.45B-$6.99B$3.12

View Complete Financial Analysis

Full income statements, balance sheets, cash flows, and AI-powered insights

Open Full Analysis

Frequently Asked Questions

What is BMY's revenue?

BMY's most recent quarterly revenue was $48.19B, representing a decline of 0.2% year-over-year.

Is BMY profitable?

BMY reported a profit of $7.05B in the most recent quarter. The net profit margin is 0.1%.

What is BMY's operating income?

Operating income data is available in the income statement.

What is BMY's earnings per share (EPS)?

BMY reported diluted earnings per share of $3.46 in the most recent quarter.

What is BMY's gross profit margin?

BMY has a gross profit margin of 72.6%, indicating the profitability of core operations before operating expenses.

Explore Categories